On-therapy monitoring of oesophageal cancer and recurrence detection: the Blood-based LIquid Sequencing Study (BLISS)
University of Oxford
Nuffield Department of Medicine
Oesophageal cancer is undergoing a therapeutic revolution, with first-generation immunotherapy trial results reading out in the next 12 months, and second-generation bispecific agents beginning evaluation alongside new targeted agents for Claudin 18.2, Her2, and FGFR. Read more
Supervisors: Dr R Owen , Dr B Schuster-Boeckler
8 April 2025
PhD Research Project
Funded PhD Project (Students Worldwide)